metipranolol has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campochiaro, PA; Chadha, R; Green, K; Kanan, Y; Khan, M; Long, D; Lorenc, VE; Sciamanna, J | 1 |
Kuncová, J; Nalos, L; Rajdl, D; Stengl, M; Švíglerová, J; Tonar, Z | 1 |
Krieglstein, GK; Lemke, JH; Mietz, H; Schlötzer-Schrehardt, U | 1 |
3 other study(ies) available for metipranolol and Disease Models, Animal
Article | Year |
---|---|
Metipranolol promotes structure and function of retinal photoreceptors in the rd10 mouse model of human retinitis pigmentosa.
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Female; Male; Metipranolol; Mice; Retinal Cone Photoreceptor Cells; Retinal Rod Photoreceptor Cells; Retinitis Pigmentosa | 2019 |
Cardiovascular parameters in rat model of chronic renal failure induced by subtotal nephrectomy.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atropine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Creatinine; Disease Models, Animal; Heart Rate; Hemodynamics; Kidney Failure, Chronic; Male; Metipranolol; Muscarinic Antagonists; Myocardial Contraction; Nephrectomy; Rats; Rats, Wistar; Time Factors; Urea; Ventricular Function, Left | 2010 |
Early conjunctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Conjunctiva; Conjunctival Diseases; Dexamethasone; Disease Models, Animal; Extracellular Matrix; Female; Glucocorticoids; Immunohistochemistry; Metipranolol; Ophthalmic Solutions; Preservatives, Pharmaceutical; Rabbits | 1997 |